Edward Nash
Stock Analyst at Canaccord Genuity
(2.36)
# 882
Out of 5,370 analysts
106
Total ratings
34.00%
Success rate
41.56%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuti... | Maintains: Strong Buy | 394 420 | 284.98 | 47.38% | 9 | May 2, 2025 | |
CLDX Celldex Therapeutics | Initiates Coverage On: Buy | 64 | 20.4 | 213.73% | 1 | Apr 28, 2025 | |
TVTX Travere Therapeutics | Maintains: Strong Buy | 45 47 | 14.73 | 219.08% | 10 | Apr 10, 2025 | |
CORT Corcept Therapeutics | Maintains: Strong Buy | 130 142 | 70.84 | 100.45% | 7 | Apr 1, 2025 | |
RANI Rani Therapeutics Hl... | Maintains: Buy | 9 9 | 0.52 | 1630.77% | 2 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 44 72 | 92.58 | -22.23% | 9 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 4 | 1.34 | 198.51% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 56 73 | 55.47 | 31.6% | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 89 | 42.68 | 108.53% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 14 | 2.54 | 451.18% | 6 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 8 | 1.42 | 463.38% | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 20 | 3.32 | 502.41% | 2 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 68 66 | n/a | n/a | 2 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 19 | n/a | n/a | 9 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 8 | 2.4 | 233.33% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 71 48 | n/a | n/a | 3 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 17 | 4.36 | 289.91% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3 2 | 2.18 | -8.26% | 4 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 17 | n/a | n/a | 2 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 900 180 | 1.73 | 10304.62% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 52 | n/a | n/a | 2 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | n/a | n/a | 1 | Apr 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 1 | n/a | n/a | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 82 | 37.03 | 121.44% | 5 | Jun 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 120 80 | 2.46 | 3152.03% | 3 | Sep 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 3 | n/a | n/a | 1 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Oct 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 48 | 15.11 | 217.67% | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 650 | 5.98 | 10769.57% | 1 | Nov 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 150 0 | n/a | n/a | 3 | Sep 22, 2017 |